Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-trypanosomatid drug discovery: progress and challenges
Manu De Rycker, Susan Wyllie, David Horn, et al.
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 35-50
Open Access | Times Cited: 126

Showing 26-50 of 126 citing articles:

Decoding post-transcriptional gene expression controls in trypanosomatids using machine learning
Michele Tinti, David Horn
Wellcome Open Research (2025) Vol. 10, pp. 173-173
Open Access
Navigating the Landscape of Academic Drug Discovery: An 18-Year Journey
Beatriz Baragaña, Laura A. T. Cleghorn
Journal of Medicinal Chemistry (2025)
Closed Access
Synthesis and Evaluation of the Antitrypanosomal Activity, Adme and DNA Binding Properties of Benzothiazoleamidoximes and Arylimidamides
Valentina Rep Kaulić, Martina Piškor, Sanja Koštrun, et al.
(2025)
Closed Access
Re-styling an old scaffold: ebsulfur analogs with improved activity and selectivity against the infective stage of trypanosomes
Cristina Quiroga, Marcelo Incerti, Diego Benítez, et al.
European Journal of Medicinal Chemistry (2025), pp. 117675-117675
Closed Access
Exploring Lamiaceae diterpenoids as potential multitarget therapeutics for leishmaniasis and chagas disease
Renata Priscila Barros de Menezes, Edileuza Bezerra de Assis, Natália Ferreira de Sousa, et al.
Molecular Diversity (2025)
Closed Access
Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment
Rik Hendrickx, Roma Melkamu, Dagimawie Tadesse, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 3
Chagas Disease across the Ages: A Historical View and Commentary on Navigating Future Challenges
Denis Séréno, Bruno Oury, Mario J. Grijalva
Microorganisms (2024) Vol. 12, Iss. 6, pp. 1153-1153
Open Access | Times Cited: 3
Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases
Anindita Bhattacharjee, Arka Bagchi, Solanki Sarkar, et al.
Life Sciences (2024) Vol. 351, pp. 122844-122844
Open Access | Times Cited: 3
Treatments and the Perspectives of Developing a Vaccine for Chagas Disease
Priscila Silva Grijó Farani, Kathryn M. Jones, Cristina Poveda
Vaccines (2024) Vol. 12, Iss. 8, pp. 870-870
Open Access | Times Cited: 3
Histone divergence in trypanosomes results in unique alterations to nucleosome structure
Gauri Deák, Hannah Wapenaar, Gorka Sandoval, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 15, pp. 7882-7899
Open Access | Times Cited: 9
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets
Mariana Laureano de Souza, Thibault Joseph William Jacques Dit Lapierre, Gabriel Marques, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 10, pp. 911-925
Closed Access | Times Cited: 9
Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites
J. Jonathan Nué-Martínez, David Cisneros, María del Valle Moreno-Blázquez, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13452-13480
Open Access | Times Cited: 8
Nanopore-Based Direct RNA Sequencing of the Trypanosoma brucei Transcriptome Identifies Novel lncRNAs
Elisabeth Kruse, H. Ulrich Göringer
Genes (2023) Vol. 14, Iss. 3, pp. 610-610
Open Access | Times Cited: 7
Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole
Diego B. Carvalho, Pedro A.N. Costa, Gisele Bulhões Portapilla, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115451-115451
Closed Access | Times Cited: 7
Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promastigotes with Distinct Virulence Profile Differently Modulate the Macrophage Functions
Rogéria Cristina Zauli, Isabelle Carlos de Souza Perez, Aline Correia Costa de Morais, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2973-2973
Open Access | Times Cited: 7
Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?
Miguel Marín, M. Allué López, Laura Gallego‐Yerga, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1055-1120
Open Access | Times Cited: 7
PEX1 is essential for glycosome biogenesis and trypanosomatid parasite survival
Lavanya Mahadevan, Hemant Arya, Andrea Droste, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
Optimization of benzenesulfonyl derivatives as anti-Trypanosomatidae agents: Structural design, synthesis, and pharmacological assessment against Trypanosoma cruzi and Leishmania infantum
Guilherme Freitas de Lima Hercos, Mariza Gabriela Faleiro de Moura Lodi Cruz, Ana Clara Cassiano Martinho, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117736-117736
Closed Access | Times Cited: 2
The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis
Kat S. Rock, Lloyd A. C. Chapman, Andrew P. Dobson, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. Supplement_2, pp. S175-S182
Open Access | Times Cited: 2
Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents
Joelien Jooste, Lesetja J. Legoabe, Kayhan Ilbeigi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 2
Pass the boron: benzoxaboroles as antiparasite drugs
Martin Zoltner, David Horn, Mark C. Field
Trends in Parasitology (2024) Vol. 40, Iss. 9, pp. 820-828
Open Access | Times Cited: 2
Neglected Tropical Diseases: A Chemoinformatics Approach for the Use of Biodiversity in Anti-Trypanosomatid Drug Discovery
Marília Valli, Thiago Henrique Doring, Edgard Marx, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 1033-1033
Open Access | Times Cited: 2
Collaborative Virtual Screening Identifies a 2-Aryl-4-aminoquinazoline Series with Efficacy in an In Vivo Model of Trypanosoma cruzi Infection
Taisuke Tawaraishi, Atsuko Ochida, Yuichiro Akao, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1221-1238
Open Access | Times Cited: 6
Identification of compounds with activity against Trypanosoma cruzi within a collection of synthetic nucleoside analogs
Berta Barnadas-Carceller, Nieves Martínez-Peinado, Laura Córdoba Gómez, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 6
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy
Yang Zheng, Magali Van den Kerkhof, Tiffany van der Meer, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10252-10264
Open Access | Times Cited: 6

Scroll to top